Background {#Sec1}
==========

Stress cardiac magnetic resonance with adenosine (CMR-A) is a valid test to rule out myocardial ischaemia. We follow-up a cohort of patients with CMR-A due to suspected myocardial ischaemia, considering patients with very high cardiovascular risk.

Methods {#Sec2}
=======

We included all patients with CMR-A between June 2009 and November 2012, considering two groups: those with a very high cardiovascular risk (prior myocardial infarction or/and Diabetes mellitus) and the rest of the patients. The follow-up was done in outpatient cardiology clinic or by phone. We analyse free-event survival considering: acute coronary syndrome (ACS), death for any cause, admission for heart failure (HF) or necessity of revascularization as endpoints. The statistical analysis was made with SPSS 20.0.

Results {#Sec3}
=======

The follow-up of 239 patients (180 male) was done. 134 (56%) were re-classified as high cardiovascular risk patients and 105 (44%) as non-high cardiovascular risk ones. The basal characteristics of each group are summarize in table [1](#Tab1){ref-type="table"}.Table 1Characteristics of the patients with CMR-A to rule out myocardial ischaemia considering cardiovascular riskHigh cardiovascular risk (n=134)Non-high cardiovascular risk (n=105)Age-years old68.0±8.363.8±11.8Diabetes mellitus-no (%)\
Basal glucose (mg/dL)\
HbA1c (%)93 (69.4)\
125±41\
7.0±1.4-\
103±33\
6.1±1.3No tobacco history-no (%)48 (35.8)55 (52.4)Arterial hypertension-no (%)97 (72.4)69 (65.7)Dyslipidaemia-no (%)104 (77.6)53 (50.5)BMI (kg/m2)29.8±6.127.1±4.7Previous ictus-no (%)12 (9.0)4 (3.1)Peripheral arterial disease-no (%)33 (24.6)7 (6.7)Previous myocardial infarction-no (%)\
PCI revascularization-no (%)\
CABG revascularization-no (%)68 (50.7)\
51 (38.1)\
29 (21.6)Result in CMR-A\
Positive-no (%)\
Negative-no (%)-\
56 (41.8)\
78 (58.2)-\
27 (25.7)\
78 (74.3)Events in follow-up-no (%)\
ACS-no (%)\
Death for any cause-no (%)\
Admission for HF-no (%)\
Revascularization-no (%)51 (38.1)\
21 (15.7)\
8 (6)\
2 (1.5)\
20 (14.9)17 (16%)\
5 (4.8)\
8 (7.6)\
3 (2.9)\
1 (1)

CMR-A was positive for myocardial ischaemia in 83 patients (35%) and negative in 156 (65%). The follow-up median was 25 months, with events in 68 patients. The results of the test and the events during the follow-up in each group are attached in table [1](#Tab1){ref-type="table"}.

The analysis of Kaplan-Meier survival curves ([1](#Fig1){ref-type="fig"} and 2), considering the cardiovascular risk and the result of the test, showed statistical differences only in very high cardiovascular risk patients (Long Rank test; p=0.024).Figure 1

Conclusions {#Sec4}
===========

In this cohort of patients with very high cardiovascular risk, those with a negative result have fewer events in the follow-up. CMR-A allows a better classification of the global cardiovascular risk
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